Wire Stories
Karolinska Development�s portfolio company SVF Vaccines initiates clinical phase 1 study of its universal Covid-19 vaccine
STOCKHOLM, Sweden, February 28, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, formerly Svenska Vaccinfabriken Produktion...